Journal Guide

Aging Medicine is a peer reviewed open access journal that aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research as well as epidemiological and translational studies in geriatrics.

Animal Models and Experimental Medicine (AMEM) is an international, open access publishing journal dedicated to disseminating research and contemporary information in the field of laboratory animal sciences.

Topics explored by AMEM include new animal models of human disease, laboratory animal biology, laboratory animal medicine, laboratory animal welfare, laboratory animal biotechnology, as well as other studies involving laboratory animals.

FASEB BioAdvances is an international open-access journal of the Federation of American Societies for Experimental Biology (FASEB) published in partnership with John Wiley and Sons. Founded in 1912, FASEB is the nation’s largest federation of U.S. biomedical societies, representing more than 130,000 researchers worldwide.

FASEB BioAdvances serves the global bioscience community by providing a vehicle for publishing well-designed and executed original research, review, and hypothesis papers, as well as reports on the replication of other published work—regardless of perceived or anticipated citation “impact.” Published articles must be of credible design and sound science.

IJU Case Reports is an open access, peer-reviewed online journal that considers new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in urology.

As healthcare professionals, authors, and publishers ourselves, the IJU Case Reports editors believe in the value of case reports and know how hard they can be to write and publish.

IJU Case Reports accepts only cases of exceptional interest and novelty. All clinical cases should be reported in a way that provide evidence showing adequate steps have been taken to minimize harm, to avoid coercion or exploitation, to protect confidentiality, to minimize the risk of physical and psychological damage, and to respect autonomy.

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Japan Architectural Review is the official peer-reviewed journal of the Architectural Institute of Japan. The journal covers all aspects of architectural design and building sciences, including perspectives offered through the lens of science, technology, engineering, economics, social science and human-centered design, architectonics and other related fields. The journal provides a forum for the exchange of ideas, innovation and information between architects, researchers and engineers, with the aim of advancing the contribution architecture can make in mitigating and resolving a broad range of problems faced locally and globally. Japan Architectural Review publishes original papers, invited reviews, design reviews and translated papers in the areas noted above. The journal is published quarterly, and all content is published open access.

Journal of Cutaneous Immunology and Allergy publishes high quality peer-reviewed manuscripts covering the entire scope of cutaneous immunology and allergy, from molecular studies to clinical investigations and observations. JCIA is the official journal of The Japanese Society for Cutaneous Immunology and Allergy, and serves as an international forum for the work of all skin researchers and dermatological scientists.

Precision Radiation Oncology is a peer-reviewed, fully open access journal which aims to offer a forum for collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and clinical research in radiation oncology. The journal is published in collaboration with the Shandong Cancer Hospital and Institute, and is supported by Sino-American Network for Therapeutic Radiology and Oncology (SANTRO), and Chinese Anti-Cancer Association (CA-CA).